| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 4 |
| 1 | TACROLIMUS | 4 |
| 2 | INFLIXIMAB | 3 |
| 3 | BASILIXIMAB | 2 |
| 4 | CAPECITABINE | 2 |
| 5 | FUROSEMIDE | 2 |
| 6 | MYCOPHENOLATE MOFETIL | 2 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 2 |
| 8 | OMEPRAZOLE | 2 |
| 9 | OMEPRAZOLE MAGNESIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SULINDAC | 1 | 0.0004 |
| 1 | BASILIXIMAB | 2 | 0.0002 |
| 2 | PIROXICAM | 1 | 0.0002 |
| 3 | CAPTOPRIL | 1 | 0.0001 |
| 4 | REGORAFENIB | 1 | 0.0001 |
| 5 | INDOMETHACIN | 1 | 0.0001 |
| 6 | MYCOPHENILIC ACID | 1 | 0.0000 |
| 7 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 8 | IMATINIB MESYLATE | 1 | 0.0000 |
| 9 | BEVACIZUMAB | 4 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 4 | Angiotensin Converting Enzyme Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Sulfonylurea [EPC] | 1 | 0.0000 |